ALEMBIC OSELTAMIVIR oseltamivir (as phosphate) 30 mg hard capsule blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

oseltamivir phosphate, Quantity: 39.411 mg

Commercializzato da:

Alembic Pharmaceuticals Australia Pty Ltd

Forma farmaceutica:

Capsule, hard

Composizione:

Excipient Ingredients: pregelatinised maize starch; purified talc; povidone; sodium stearylfumarate; croscarmellose sodium; propylene glycol; indigo carmine; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; titanium dioxide; purified water; iron oxide yellow; iron oxide red; Gelatin

Via di somministrazione:

Oral

Confezione:

10

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Oseltamivir Phosphate is indicated for the treatment of infections due to influenza A and B viruses in adults and children including full-term neonates. Treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,Oseltamivir Phosphate is indicated for the prevention of influenza in adults and children aged 1 year and older. Vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Dettagli prodotto:

Visual Identification: Opaque Light yellow cap/opaque Light yellow body hard gelatin capsules size 4 having imprinting A 292 on cap with blue ink.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2022-11-17